Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper
David F Schaeffer, Jennifer Chan, Jason Morin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2011
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
Alexander M M Eggermont, Stefan Suciu, Alessandro Testori, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Shamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Cancers
|
November 13, 2025
Evaluating the Role of Liquid Biopsy to Detect Pathogenic Homologous Recombination Repair (HRR) Gene Alterations in Metastatic Prostate Cancer
Soumaya Labidi, Belinda Jiao, Shirley Tam, et al.
Proteomics. Clinical Applications
|
July 10, 2020
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
Cancer Treatment and Research Communications
|
November 13, 2021
Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas
Nicole Ezer, Hangjun Wang, Andrea Gomez Corredor, et al.
The Analyst
|
September 29, 2021
A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
Cancers
|
December 7, 2019
Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data
Bernhard Blank-Landeshammer, Vincent R Richard, Georgia Mitsa, et al.
International Journal of Molecular Sciences
|
April 23, 2022
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens
Georgia Mitsa, Qianyu Guo, Christophe Goncalves, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper
David F Schaeffer, Jennifer Chan, Jason Morin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 8, 2011
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
Alexander M M Eggermont, Stefan Suciu, Alessandro Testori, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Shamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Cancers
|
November 13, 2025
Evaluating the Role of Liquid Biopsy to Detect Pathogenic Homologous Recombination Repair (HRR) Gene Alterations in Metastatic Prostate Cancer
Soumaya Labidi, Belinda Jiao, Shirley Tam, et al.
Proteomics. Clinical Applications
|
July 10, 2020
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
Cancer Treatment and Research Communications
|
November 13, 2021
Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas
Nicole Ezer, Hangjun Wang, Andrea Gomez Corredor, et al.
The Analyst
|
September 29, 2021
A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines and tumor tissues
Bjoern C Froehlich, Robert Popp, Constance A Sobsey, et al.
Cancers
|
December 7, 2019
Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data
Bernhard Blank-Landeshammer, Vincent R Richard, Georgia Mitsa, et al.
International Journal of Molecular Sciences
|
April 23, 2022
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens
Georgia Mitsa, Qianyu Guo, Christophe Goncalves, et al.
Page
of 8